(Q42831336)

English

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo

scientific article published on March 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 November 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo (English)

1 reference

Europe PubMed Central

8 November 2017

author name string

N B Lydon

1

1 reference

Europe PubMed Central

8 November 2017

H Mett

2

1 reference

Europe PubMed Central

8 November 2017

M Mueller

3

1 reference

Europe PubMed Central

8 November 2017

M Becker

4

1 reference

Europe PubMed Central

8 November 2017

R M Cozens

5

1 reference

Europe PubMed Central

8 November 2017

D Stover

6

1 reference

Europe PubMed Central

8 November 2017

D Daniels

7

1 reference

Europe PubMed Central

8 November 2017

P Traxler

8

1 reference

Europe PubMed Central

8 November 2017

E Buchdunger

9

1 reference

Europe PubMed Central

8 November 2017

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

8 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

8 November 2017

76

1 reference

Europe PubMed Central

8 November 2017

1

1 reference

Europe PubMed Central

8 November 2017

154-163

1 reference

Europe PubMed Central

8 November 2017

A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980330%2976%3A1%3C154%3A%3AAID-IJC24%3E3.0.CO%3B2-B

21 January 2018

Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980330%2976%3A1%3C154%3A%3AAID-IJC24%3E3.0.CO%3B2-B

21 January 2018

Purification and biochemical characterization of non-myristoylated recombinant pp60c-src kinase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980330%2976%3A1%3C154%3A%3AAID-IJC24%3E3.0.CO%3B2-B

21 January 2018

RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.92.7.2558

RETRACTED: 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.91.6.2334

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/IJC.2910430519

cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF

0 references

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

0 references

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

0 references

Oncogenes, growth factors, and signal transduction

0 references

Expression and partial characterization of rat protein kinase C-delta and protein kinase C-zeta in insect cells using recombinant baculovirus

0 references

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

0 references

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

0 references

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase

0 references

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

0 references

Increase of the Catalytic Activity of Phospholipase C-γ1 by Tyrosine Phosphorylation

0 references

Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor

0 references

The pathway to signal achievement

0 references

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

0 references

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

0 references

Receptors for epidermal growth factor and other polypeptide mitogens

0 references

4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase

0 references

Tyrosine kinase inhibition: an approach to drug development

0 references

SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins

0 references

Structure and function of human amphiregulin: a member of the epidermal growth factor family

0 references

Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors

0 references

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies

0 references

A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient

0 references

The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231.

0 references

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

0 references

Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.

0 references

Structural alterations of the epidermal growth factor receptor gene in human gliomas

0 references

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

0 references

Identifiers

10.1002/(SICI)1097-0215(19980330)76:1<154::AID-IJC24>3.0.CO;2-B

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42831336&oldid=2073716365"